Treatment Options for Niemann-Pick Type C
Por um escritor misterioso
Descrição
Elizabeth Berry-Kravis, MD, PhD, co-director of the Molecular Diagnostics Section of the Genetic Laboratory at Rush Medical College in Chicago, describes dif
Niemann-Pick disease types A and B (NORD): Video
Advancements in Niemann-Pick Disease Type C Treatments
Niemann-Pick Disease Type C Treatment Market Size & Trends 2020- expected to reach US$ 378.8 Million With CAGR of 42.3% by 2027, Orphazyme A/S, Cyclo Therapeutics, Inc., and Johnson & Johnson
5 Most Promising Companies offering hope to patients with Niemann-Pick Type C
Niemann–Pick Disease Type C
DelveInsight Business Research LLP on LinkedIn: Niemann-Pick Disease Type C Market to Proliferate by 2032, Predicts…
Niemann-Pick disease type C
Combination therapy a potential strategy for treating Niemann-Pick disease
Imaging of neuroinflammation in adult Niemann-Pick type C disease
Liposome-targeted recombinant human acid sphingomyelinase: Production, formulation, and in vitro evaluation - ScienceDirect
Niemann-Pick disease A or B in four pediatric patients and SMPD1 mutation carrier frequency in the Mexican population
Correlation of age of onset and clinical severity in Niemann–Pick disease type C1 with lysosomal abnormalities and gene expression
Gene therapy shows promise for treating Niemann-Pick disease type C1
de
por adulto (o preço varia de acordo com o tamanho do grupo)
